Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 106 AL 120

Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change

Graff-Radford J, Karliner L, Barnes DE, Frisoni GB, Sperling R, Villain N, Benzinger TLS, Teunissen C, Jack CR Jr.

Lancet Neurol. 2026 Oct;25(10):952-964. doi: 10.1016/S1474-4422(26)00248-6.

The complexities of diagnosing young-onset Alzheimer's dementia and the need for swift identification

Schild AK, Bartels C, Dodel R.

Expert Rev Neurother. 2026 Oct;26(10):923-941. doi: 10.1080/14737175.2026.2733193. Epub 2026 Sep 23.

Blood-based biomarkers in the anti-amyloid era of Alzheimer's disease: clinical utility, implementation challenges, and future directions

Ho BL, Yang YH.

Neurodegener Dis Manag. 2026 Sep 26:1-17. doi: 10.1080/17582024.2026.2734618. Online ahead of print.

Tau-PET correlates of mild behavioral impairment in preclinical and prodromal Alzheimer's disease: A head-to-head comparison of Flortaucipir and MK6240

Bizzi I, Macedo AC, Trudel L, Therriault J, Rahmouni N, Lussier FZ, Tissot C, Bezgin G, Aumont É, Chan T, Hosseini SA, Oliva-Lopez D, Gonçalves MP, Povala G, Ferreira PCL, Bellaver B, Amaral L, Ruppert E, Medeiros MS, Mroué R, Rocha A, Ng KP, Zimmer ER, Masdeu J, Pascual B, Lowe VJ, Oh H, Soleimani-Meigooni DN, Fortea J, Ismail Z, Baker S, Pascoal TA, Rosa-Neto P; HEAD Study.

Alzheimers Dement. 2026 Oct;22(10):e71861. doi: 10.1002/alz.71861.

Integrative prediction of Alzheimer's disease and related dementias using multi-omics aging clocks and genetic data

Mostafaei S, Gustavsson K, Hagelin H, Mak JKL, Vu TN, Karlsson IK, Hägg S.

Alzheimers Dement. 2026 Oct;22(10):e71869. doi: 10.1002/alz.71869.

Microglia-derived extracellular vesicle content as a biomarker for early detection of Alzheimer's disease

Woudstra AL, Holtman L, van Vliet EA.

Transl Neurodegener. 2026 Sep 30;15(1):51. doi: 10.1186/s40035-026-00587-9.

Longitudinal clinical outcomes after amyloid clearance in aducanumab phase 3 studies

Pang M, Brothers HM, O'Gorman J, Murphy J, Zabar Y, Lasky T, Shen C, Rubino I, Knopman D.

Alzheimers Dement. 2026 Oct;22(10):e71758. doi: 10.1002/alz.71758.

Plasma p-tau217 as a biomarker for Alzheimer's disease: diagnostic and prognostic value in clinical and population-based studies

Gerson G, Nogueira GN, Teixeira MJ.

Arq Neuropsiquiatr. 2026 Oct;84(10):1-8. doi: 10.1055/s-0046-1829032. Epub 2026 Oct 9.

Tau-PET subtype modifies the association between plasma p-tau217 and memory in Alzheimer's disease

Zheng L, Ghanbarian E, Albarrán Morillo C, Younes K, Glover CM, Rabin LA, Grill JD, Ewers M, Sajjadi SA, Ezzati A; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Health and Aging Brain (HABS-HD) Study Team; PREVENT-AD Research Group.

medRxiv [Preprint]. 2026 Sep 28:2026.09.25.26363629. doi: 10.64898/2026.09.25.26363629.

Blood-based multiplex nanobiosensing of Alzheimer's disease biomarkers: from nanoengineered ınterfaces to clinical translation

Pehlivan ZN, Zıkşahna K, Adıyıl R, Ihlamur M.

Metab Brain Dis. 2026 Oct 13;41(1):234. doi: 10.1007/s11011-026-01993-8.

Microglial dynamics associate with the spatial pattern of tau deposition in early Alzheimer's disease

Öchsner M, Brendel M, Franzmeier N, Trappmann L, Zaganjori M, Ersoezlue E, Kurz C, Haeckert J, Utecht J, Schirge PM, Papazov B, Pogarell O, Janowitz D, Buerger K, Ewers M, Palleis C, Weidinger E, Biechele G, Schuster S, Finze A, Eckenweber F, Rupprecht R, Rominger A, Goldhardt O, Grimmer T, Keeser D, Stoecklein S, Dietrich O, Bartenstein P, Levin J, Höglinger G, Perneczky R, Rauchmann BS.

Alzheimers Res Ther. 2026 Oct 12;18(1):232. doi: 10.1186/s13195-026-02230-1.

Sleep Spindles and Slow Oscillations as Potential Biomarkers and Therapeutic Targets in Mild-to-Moderate Alzheimer's Disease

Páez A, Piñol-Ripoll G, Dakterzada F, Dang-Vu TT.

Curr Neurol Neurosci Rep. 2026 Oct 20;26(1):58. doi: 10.1007/s11910-026-01528-9.

Osteoporosis and Alzheimer's Disease: The Role of Sclerostin

Gagiano L, Chen Z, Blakeney WG, Jones C, Mastaglia F, Zheng M, Yuan J.

Curr Osteoporos Rep. 2026 Oct 21;24(1):44. doi: 10.1007/s11914-026-00993-y.

Association Between Plasma N-Terminal Tau, Cognitive Decline, and Neurodegeneration in the ADNI Cohort

Rao Y, Liu L, Ostaszewski BL, Anderson AK, Pinilla V, Shirzadi Z, Laho EM, Stern AM, Yau WW, Yang HS, Buckley RF, Ashton NJ, Denkinger MN, Sperling RA, Selkoe DJ, Chhatwal JP, Schultz SA; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2026 Nov 24;107(10):e218564. doi: 10.1212/WNL.0000000000218564. Epub 2026 Oct 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias